Previous Close | 4.0200 |
Open | 4.1400 |
Bid | 2.9700 x 200 |
Ask | 5.3200 x 200 |
Day's Range | 4.0000 - 4.1400 |
52 Week Range | 3.5100 - 44.8000 |
Volume | |
Avg. Volume | 22,262 |
Market Cap | 2.742M |
Beta (5Y Monthly) | 0.66 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -33.6300 |
Earnings Date | May 10, 2024 - May 14, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 240.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for BPTH
Dallas, Texas--(Newsfile Corp. - March 27, 2024) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q4 2023. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: ...
Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q4 2023 Earnings Call Transcript March 8, 2024 Bio-Path Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome to the Bio-Path Holdings Full Year 2023 Earnings Conference Call. […]
Q4 2023 Bio Path Holdings Inc Earnings Call